DexCom has been a great trade. While the S&P 500 was flat, the stock price has climbed by 15.6% to $87 per share. This was ...

Key Insights DexCom's estimated fair value is US$116 based on 2 Stage Free Cash Flow to Equity DexCom is estimated ...

The stock's fall snapped a two-day winning streak.

In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.

DexCom Inc. closed 34.58% short of its 52-week high of $132.26, which the company reached on May 17th.

Dexcom (Nasdaq: DXCM) today announced a significant internal promotion for a longtime member of its leadership team.

Internationally, Dexcom has seen pockets of strength in key markets, such as Japan and France, where recent type 2 diabetes coverage expansions have driven growth. New Product Launch: Dexcom plans to ...

DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose biosensing, today announced the promotion of Jake Leach to president, in addition to his current role as chief ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A strong first-quarter 2025 performance and a series of favorable coverage decisions are ...

URA has entered the consumer diabetes space, offering a new glucose feature for its ring that uses insights from Dexcom’s CGM Stelo.

Shares of DexCom jumped over 15% to pace the S&P 500's advancers Friday, a day after the maker of glucose monitoring devices ...